MENU
+Compare
RNLXY
Stock ticker: OTC
AS OF
Sep 5 closing price
Price
$0.17
Change
+$0.01 (+6.25%)
Capitalization
26.04M

RNLXY Renalytix plc Forecast, Technical & Fundamental Analysis

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more

RNLXY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNLXY with price predictions
Sep 05, 2025

RNLXY's RSI Indicator climbs out of oversold territory

The RSI Oscillator for RNLXY moved out of oversold territory on August 13, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In of the 44 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on RNLXY as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNLXY just turned positive on August 25, 2025. Looking at past instances where RNLXY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RNLXY advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where RNLXY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNLXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RNLXY broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (21.546). P/E Ratio (0.000) is within average values for comparable stocks, (81.565). RNLXY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.758). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (5.203) is also within normal values, averaging (104.827).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RNLXY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNLXY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNLXY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RNLXY is expected to report earnings to fall 40.00% to -2 cents per share on November 04

Renalytix plc RNLXY Stock Earnings Reports
Q2'25
Est.
$-0.03
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.03
The last earnings report on March 18 showed earnings per share of -5 cents, missing the estimate of -2 cents. With 12.46K shares outstanding, the current market capitalization sits at 26.04M.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCNNF0.040.01
+23.08%
QUEST CRITICAL METALS INC.
LIMAF56.030.38
+0.68%
Linamar Corporation
HOKCY0.85N/A
N/A
Hong Kong & China Gas Co., Ltd.
ABCCF7.00N/A
N/A
ABC Arbitrage SA
EQFN14.75-1.00
-6.35%
Equitable Financial Corp.

Groups containing RNLXY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNLXY
1D Price
Change %
RNLXY100%
+2.55%
Health Services
category (439 stocks)
-5%
Poorly correlated
-0.02%
Services to the Health Industry
category (96 stocks)
-7%
Poorly correlated
-1.85%